TURNING POINT THERAPEUTICS

turning-point-therapeutics-logo

Turning Point Therapeutics is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. They focus on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating the tumor microenvironment and tumor immunity.
#SimilarOrganizations #People #Financial #Event #Website #More

TURNING POINT THERAPEUTICS

Industry:
Biotechnology Health Care Pharmaceutical Precision Medicine Therapeutics

Founded:
2013-10-08

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.tptherapeutics.com

Total Employee:
251+

Status:
Active

Contact:
(858)926-5251

Email Addresses:
[email protected]

Total Funding:
1.18 B USD

Technology used in webpage:
Domain Not Resolving SPF Amazon Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy SSL Invalid Certificate Dates Amazon Oregon Region Debian


Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

arpeggio-bio-logo

Arpeggio Bio

Arpeggio builds technology to watch and learn how drugs work.

navrogen-logo

Navrogen

Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.

nephrodi-therapeutics-logo

NephroDI Therapeutics

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.

stillmind-therapeutics-logo

Stillmind Therapeutics

Stillmind uses AI, automation and biology-first principles to create precision medicines for brain disorders, starting with bipolar

oric-pharmaceuticals-logo

ORIC Pharmaceuticals

ORIC Pharmaceuticals operates as a biopharmaceutical company.

pacylex-logo

Pacylex

Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.

pinpoint-therapeutics-logo

Pinpoint Therapeutics

Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.


Current Advisors List

hongbo-lu_image

Hongbo Lu Board Member @ Turning Point Therapeutics
Board_member

j-jean-cui_image

J. Jean Cui Board Member @ Turning Point Therapeutics
Board_member
2013-11-01

jacob-chacko_image

Jacob Chacko Board Member @ Turning Point Therapeutics
Board_member
2018-11-01

athena-countouriotis_image

Athena Countouriotis Board Member @ Turning Point Therapeutics
Board_member

patrick-machado_image

Patrick Machado Board Member @ Turning Point Therapeutics
Board_member
2019-05-01

carl-l-gordon_image

Carl L. Gordon Board Member @ Turning Point Therapeutics
Board_member

simeon-george_image

Simeon George Board Member @ Turning Point Therapeutics
Board_member
2017-05-01

Current Employees Featured

siegfried-reich_image

Siegfried Reich
Siegfried Reich Executive Vice President, CSO @ Turning Point Therapeutics
Executive Vice President, CSO
2020-03-01

j-jean-cui_image

J. Jean Cui
J. Jean Cui Scientific Founder & Board Member @ Turning Point Therapeutics
Scientific Founder & Board Member
2020-02-01

john-kc-lim_image

John K.C. Lim
John K.C. Lim Senior Vice President, Clinical Operations and Regulatory Affairs @ Turning Point Therapeutics
Senior Vice President, Clinical Operations and Regulatory Affairs

adam-d-levy_image

Adam D. Levy
Adam D. Levy Senior Vice President, Investor Relations and Corporate Communications @ Turning Point Therapeutics
Senior Vice President, Investor Relations and Corporate Communications
2021-11-01

mohammad-hirmand_image

Mohammad Hirmand
Mohammad Hirmand Executive Vice President & Chief Medical Officer @ Turning Point Therapeutics
Executive Vice President & Chief Medical Officer

homa-yeganegi_image

Homa Yeganegi
Homa Yeganegi Senior Vice President, Project Team Leader and Head of Medical Affairs @ Turning Point Therapeutics
Senior Vice President, Project Team Leader and Head of Medical Affairs
2020-01-06

Founder


j-jean-cui_image

J. Jean Cui

y-peter-li_image

Y. Peter Li

Stock Details


Company's stock symbol is NASDAQ:TPTX

Investors List

lilly-asia-ventures_image

Lilly Asia Ventures

Lilly Asia Ventures investment in Private Equity Round - Turning Point Therapeutics

hbm-healthcare-investments-ag_image

HBM Healthcare Investments

HBM Healthcare Investments investment in Private Equity Round - Turning Point Therapeutics

foresite-capital_image

Foresite Capital

Foresite Capital investment in Private Equity Round - Turning Point Therapeutics

kenson-ventures_image

Kenson Ventures

Kenson Ventures investment in Private Equity Round - Turning Point Therapeutics

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Private Equity Round - Turning Point Therapeutics

venbio_image

venBio Partners

venBio Partners investment in Private Equity Round - Turning Point Therapeutics

nextech-invest_image

Nextech Invest

Nextech Invest investment in Private Equity Round - Turning Point Therapeutics

sr-one_image

SR One

SR One investment in Private Equity Round - Turning Point Therapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Private Equity Round - Turning Point Therapeutics

sr-one_image

SR One

SR One investment in Series C - Turning Point Therapeutics

Official Site Inspections

http://www.tptherapeutics.com

  • Host name: 165.89.235.20
  • IP address: 165.89.235.20
  • Location: Trenton United States
  • Latitude: 40.2187
  • Longitude: -74.7404
  • Metro Code: 504
  • Timezone: America/New_York
  • Postal: 08629

Loading ...

More informations about "Turning Point Therapeutics"

Turning Point Therapeutics - Crunchbase Company โ€ฆ

Contact Email [email protected] Phone Number (858)926-5251 Turning Point Therapeutics is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer โ€ฆSee details»

Turning Point Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...

Www.tptherapeutics.com. Public Company | Subsidiary Company | 2013 | California, United States | 250-500 | NASDAQ: TPTX | www.tptherapeutics.com. Last update 01 Nov 2024. Overview. โ€ฆSee details»

Turning Point Therapeutics - LinkedIn

Turning Point Therapeutics Biotechnology Research San Diego, CA 13,543 followers A precision oncology company, driven to develop therapies that mark a turning point for patients.See details»

TP Therapeutics - Company Profile & Staff Directory - ContactOut

TP Therapeutics, Inc. is a structure-based drug design pharmaceutical company founded by Dr. J. Jean Cui, the lead inventor of Pfizer's Xalkori(TM) (generic name: crizotinib), the precision โ€ฆSee details»

Turning Point Therapeutics - Golden

Turning Point Therapeutics, Inc. is a San Diego-based clinical-stage drug design company that specializes in the discovery and development of targeted cancer therapies designed to โ€ฆSee details»

Turning Point Therapeutics - Craft

Turning Point Therapeutics $30.83 m in annual revenue in FY 2021. See insights on Turning Point Therapeutics including office locations, competitors, revenue, financials, executives, โ€ฆSee details»

TP Therapeutics - VentureRadar

Website: http://www.tptherapeutics.com/ Develops targeted therapies for blood-related cancers, with a focus on pacritinib, an oral JAK2 inhibitor for myelofibrosis ...See details»

TP Therapeutics - Company Profile - Tracxn

Dec 6, 2024 TP Therapeutics - Developer of targeted cancer therapies. Acquired by Bristol-Myers Squibb. Raised a total funding of $64.4M over 4 rounds from 12 investors. Founded by โ€ฆSee details»

TP Therapeutics - Golden

TP Therapeutics is a clinical-stage biopharmaceutical company that is focusing on overcoming drug resistance in precision medicines for cancer and other diseases.See details»

Turning Point Therapeutics Granted Breakthrough Therapy โ€ฆ

SAN DIEGO, May 10, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted โ€ฆSee details»

Turning Point Therapeutics, Inc. (Turning Point Therapeutics, Inc ...

ไบ†่งฃTurning Point Therapeutics, Inc. (Turning Point Therapeutics, Inc.)ๅ…ฌๅธ็š„่ฏ็‰ฉ็ฎก็บฟ๏ผŒๆฒป็–—้ข†ๅŸŸ๏ผŒๆŠ€ๆœฏๅนณๅฐ๏ผŒไปฅๅŠๅฎƒ็š„21้กนไธดๅบŠ่ฏ•้ชŒ, 296็ฏ‡ๆ–ฐ้—ปๅ’Œ6็ฏ‡ๆ–‡็Œฎ๏ผŒ็–พ็—…้ข†ๅŸŸ:่‚ฟ็˜ค๏ผŒ็ฅž็ป็ณป็ปŸ็–พ็—…๏ผŒ โ€ฆSee details»

Athena Countouriotis, M.D. | Avenzo Therapeutics

Co-Founder, Chief Executive Officer. Athena Countouriotis, M.D., is co-founder, President, Chief Executive Officer and Chairperson of Avenzo Therapeutics.See details»

Turning Point Therapeutics Names Former Celgene Chairman and โ€ฆ

SAN DIEGO, May 25, 2021 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target โ€ฆSee details»

Bristol Myers Squibb to Acquire Turning Point Therapeutics, a

Jun 3, 2022 Bristol Myers Squibb to Commence All-Cash Tender Offer to Acquire All Outstanding Shares of Turning Point Therapeutics for $76.00 per Share. NEW YORK& SAN โ€ฆSee details»

Turning Point Therapeutics Granted Breakthrough Therapy โ€ฆ

SAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target โ€ฆSee details»

Turning Point Therapeutics, Inc. (TPTX) 10K Annual Reports & 10Q โ€ฆ

Feb 28, 2022 Exhibit 99.1 Contact: Adam D. Levy, Ph.D., M.B.A. [email protected]. 858-867-6366 TURNING POINT THERAPEUTICS REPORTS FOURTH-QUARTER AND FULL โ€ฆSee details»

Turning Point Therapeutics, Inc (@TPTherapeutics) / Twitter

Apr 21, 2016 @TPTherapeutics Jun 24, 2022 Turning Point Therapeutics and MD Anderson Announce Strategic Alliance to Advance Precision Cancer Therapies: https:// bit.ly/3yfPvQSee details»

Turning Point Therapeutics Announces Additional Details for Three โ€ฆ

Management to host webcast and conference call on October 7 at 8 a.m. ETSAN DIEGO, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a โ€ฆSee details»

Turning Point Therapeutics Granted Breakthrough Therapy

SAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation...See details»

Recommended Stories - Yahoo Finance

The discussion will be accessible through the "Investors" section of tptherapeutics.com or by dialing (877) 388-2118 (in the United States) or (470) 495-9489 (outside the U.S.) using โ€ฆSee details»

linkstock.net © 2022. All rights reserved